Sedation and analgesia in the intensive care unit: Evaluating the role of dexmedetomidine

1 January 2007

journal article
review article
Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy

Vol. 64 (1) , 37-44
https://doi.org/10.2146/ajhp050508

Abstract

Purpose. A review highlighting the application of sedatives and analgesics in the intensive care unit (ICU) setting, with a focus on the use of dexmedetomidine, is presented.

Keywords

This publication has 42 references indexed in Scilit:

Propofol: An Immunomodulating Agent
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
PIES Method of Critique
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2004
Comparing Dexmedetomidine Prescribing Patterns and Safety in the Naturalistic Setting Versus Published Data
Annals of Pharmacotherapy, 2004
Propofol
CNS Drugs, 2003
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
Critical Care Medicine, 2002
NEW AGENTS FOR SEDATION IN THE INTENSIVE CARE UNIT
Critical Care Clinics, 2001
Sedation in the Intensive Care Unit
JAMA, 2000
Dexmedetomidine
Drugs, 2000
Patients Requiring Sedation
Critical Care Clinics, 1995
Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients
Critical Care Medicine, 1992